CCCC vs RF
C4 Therapeutics Inc (CCCC) versus RF (RF) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
RF does not have a complete income-statement cache yet.
CCCC currently screens at market cap $425.7M. RF currently screens at market cap $0.
Not investment advice. Open the CCCC and RF stock pages for the full models.
Not investment advice.